http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111317740-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
filingDate | 2020-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111317740-B |
titleOfInvention | Notch signaling pathway inhibitory composition and application in anti-prostate cancer bone metastasis |
abstract | The invention discloses a Notch signaling pathway inhibitory composition and its application in anti-prostate cancer bone metastasis. The present invention finds that the combined use of andrographolide and diosgenin can exert a synergistic effect, more efficiently inhibit the notch signaling pathway, and further effectively exert the anti-prostate cancer bone metastasis effect, including inhibiting the proliferation, migration, invasion, Secreted expression of adhesion and transfer related proteins. |
priorityDate | 2020-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 209.